Filing Details

Accession Number:
0001181431-11-037199
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-17 11:08:12
Reporting Period:
2011-06-15
Filing Date:
2011-06-17
Accepted Time:
2011-06-17 11:08:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1400431 Patheon Inc PTI Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1286396 Michael Lytton 4721 Emperor Blvd
Suite 200
Durham NC 27703
Evp Corporate Development & St No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Restricted Voting Shares Acquisiton 2011-06-15 27,700 $2.04 27,700 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Restricted Voting Shares Employee Stock Option (right to buy) Acquisiton 2011-06-15 400,000 $0.00 400,000 $2.13
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
400,000 2021-06-15 No 4 A Direct
Footnotes
  1. The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.01 to $2.04, inclusive. The reporting person undertakes to provide to Patheon Inc., any security holder of Patheon Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1). The amounts reported in column 4 and this footnote (1) were converted from Canadian dollars into U.S. dollars based on the June 15, 2011 closing exchange rate of 0.9790 Canadian dollars per U.S. dollar as quoted by Reuters.
  2. The exercise price was converted from C$2.09 based on the June 15, 2011 closing exchange rate of 0.9790 Canadian dollars per U.S. dollar as quoted by Reuters. The actual exercise price will be the Canadian dollar amount regardless of the exchange rate on the date of grant or of exercise.
  3. The option vests in five equal annual installments on June 15, 2012, June 15, 2013, June 15, 2014, June 15, 2015, and June 15, 2016.